Literature DB >> 12954572

Hepatitis C and B-cell lymphoma.

N C Turner1, G Dusheiko, A Jones.   

Abstract

The association between the hepatitis C virus and B-cell non-Hodgkin's lymphomas is controversial. We review the epidemiological evidence behind the association, and look at the reasons behind the variation in study findings. There is increasing evidence of the pathogenesis of hepatitis C-associated lymphoma. Treatment of the hepatitis C virus with antiviral therapy may lead to the regression of some low-grade lymphomas. The management of other hepatitis C-associated lymphomas is similar to that of conventional lymphoma, although viral reactivation and subsequent immune reconstitution hepatitis can complicate chemotherapy.

Entities:  

Mesh:

Year:  2003        PMID: 12954572     DOI: 10.1093/annonc/mdg363

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  13 in total

Review 1.  Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer.

Authors:  Harrys A Torres; Marta Davila
Journal:  Nat Rev Clin Oncol       Date:  2012-01-24       Impact factor: 66.675

2.  HCV non-structural protein 3 and HCV RNA genome in non-Hodgkin lymphoma and transition of the serum HCV RNA level: a retrospective analysis in one institution.

Authors:  Souichi Shiratori; Yutaka Tsutsumi; Takahito Kawamura; Kazuhiro Kudo; Norihiko Shimoyama; Nobuo Masauzi; Junji Tanaka; Masahiro Asaka; Masahiro Imamura
Journal:  Int J Hematol       Date:  2008-03-06       Impact factor: 2.490

3.  Viral and non-viral risk factors for non-Hodgkin's lymphoma in Egypt: heterogeneity by histological and immunological subtypes.

Authors:  Lenka Goldman; Sameera Ezzat; Nadia Mokhtar; Amany Abdel-Hamid; Nathan Fowler; Iman Gouda; Soheir Abdel Latif Eissa; Mohamed Abdel-Hamid; Christopher A Loffredo
Journal:  Cancer Causes Control       Date:  2009-03-05       Impact factor: 2.506

4.  Risk of malignant lymphoma following viral hepatitis infection.

Authors:  Pierluigi Cocco; Giovanna Piras; Maria Monne; Antonella Uras; Attilio Gabbas; Maria G Ennas; Angelo Palmas; Marco Murineddu; Stefania Collu; Massimo Melis; Marco Rais; Pierfelice Todde; Maria G Cabras; Emanuele Angelucci; Giovannino Massarelli; Alexandra Nieters
Journal:  Int J Hematol       Date:  2008-05-01       Impact factor: 2.490

5.  Diagnostic and therapeutic quandaries in a patient with primary hepatic lymphoma and concurrent hepatitis C infection.

Authors:  Muhajir Mohamed; Ruchira Fernando
Journal:  Indian J Hematol Blood Transfus       Date:  2014-07-16       Impact factor: 0.900

6.  Primary spleen lymphoma associated with hepatitis C virus infection.

Authors:  Ricardo Cotta-Pereira; Roberta Acar; Carlos Eduardo Brandão Mello; Antonio Carlos Iglesias; Carlos Alberto Basílio-de-Oliveira
Journal:  BMJ Case Rep       Date:  2011-02-09

Review 7.  The role of infectious agents in the etiology of ocular adnexal neoplasia.

Authors:  Varun Verma; Defen Shen; Pamela C Sieving; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2008 Jul-Aug       Impact factor: 6.048

8.  B cells in chronically hepatitis C virus-infected individuals lack a virus-induced mutation signature in the TP53, CTNNB1, and BCL6 genes.

Authors:  Felicia Anna Tucci; Ruth Broering; Patricia Johansson; Joerg F Schlaak; Ralf Küppers
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

9.  HCV infection and B-cell lymphomagenesis.

Authors:  Masahiko Ito; Hideki Kusunoki; Keiko Mochida; Kazunari Yamaguchi; Toshiaki Mizuochi
Journal:  Adv Hematol       Date:  2011-07-20

10.  Peripheral B cells as reservoirs for persistent HCV infection.

Authors:  Masahiko Ito; Hideki Kusunoki; Toshiaki Mizuochi
Journal:  Front Microbiol       Date:  2011-08-31       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.